CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | PYOTT DAVID E I Director | Grant or award | +671 | 1,582 | ||
| 2026-05-20 | PYOTT DAVID E I Director | Grant or award · Stock Option (Right to Buy) | +1,441 | 1,441 | ||
| 2026-05-20 | KELLOGG PETER N Director | Grant or award | +671 | 1,446 | ||
| 2026-05-20 | KELLOGG PETER N Director | Grant or award · Stock Option (Right to Buy) | +1,441 | 1,441 | ||
| 2026-05-20 | HAMBURG MARGARET A Director | Grant or award | +671 | 1,582 | ||
| 2026-05-20 | HAMBURG MARGARET A Director | Grant or award · Stock Option (Right to Buy) | +1,441 | 1,441 | ||
| 2026-05-20 | BRANDICOURT OLIVIER Director | Grant or award | +671 | 1,446 | ||
| 2026-05-20 | BRANDICOURT OLIVIER Director | Grant or award · Stock Option (Right to Buy) | +1,441 | 1,441 | ||
| 2026-05-20 | Ausiello Dennis A Director | Grant or award | +671 | 1,582 | ||
| 2026-05-20 | Ausiello Dennis A Director | Grant or award · Stock Option (Right to Buy) | +1,441 | 1,441 | ||
| 2026-05-20 | Arbuckle Stuart A Director | Grant or award | +671 | 671 | ||
| 2026-05-20 | Arbuckle Stuart A Director | Grant or award · Stock Option (Right to Buy) | +1,441 | 1,441 | ||
| 2026-05-13 | SCHULMAN AMY W Director | Option exercise | +11,250 | $70.20 | $790K | 23,211 |
| 2026-05-13 | SCHULMAN AMY W Director | Option exercise · Stock Option (Right to Buy) | −11,250 | 0 | ||
| 2026-04-06 | McLaughlin Melissa Chief Human Resources Officer | Sale 10b5-1 | −56 | $320.14 | $18K | 11,673 |
| 2026-04-06 | McLaughlin Melissa Chief Human Resources Officer | Sale 10b5-1 | −909 | $329.76 | $300K | 10,764 |
| 2026-04-06 | McLaughlin Melissa Chief Human Resources Officer | Sale 10b5-1 | −829 | $330.46 | $274K | 9,935 |
| 2026-04-06 | McLaughlin Melissa Chief Human Resources Officer | Sale 10b5-1 | −293 | $331.89 | $97K | 9,642 |
| 2026-04-06 | McLaughlin Melissa Chief Human Resources Officer | Sale 10b5-1 | −199 | $333.94 | $66K | 9,443 |
| 2026-04-02 | McLaughlin Melissa Chief Human Resources Officer | Sale 10b5-1 | −265 | $316.61 | $84K | 13,088 |
Page 2 of 41 · 816 trades